Epoxyeicosatrienoic acid metabolites inhibit Kir4.1/Kir5.1 in the distal convoluted tubule.


Journal

American journal of physiology. Renal physiology
ISSN: 1522-1466
Titre abrégé: Am J Physiol Renal Physiol
Pays: United States
ID NLM: 100901990

Informations de publication

Date de publication:
01 06 2020
Historique:
pubmed: 21 4 2020
medline: 8 10 2020
entrez: 21 4 2020
Statut: ppublish

Résumé

Cytochrome

Identifiants

pubmed: 32308018
doi: 10.1152/ajprenal.00018.2020
pmc: PMC7311705
doi:

Substances chimiques

Amides 0
Enzyme Inhibitors 0
Kcnj10 (channel) 0
Kcnj16 protein, mouse 0
N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide 0
Potassium Channel Blockers 0
Potassium Channels, Inwardly Rectifying 0
Arachidonic Acid 27YG812J1I
11,12-epoxy-5,8,14-eicosatrienoic acid 5DOQ38R4UW
14,15-epoxy-5,8,11-eicosatrienoic acid 81276-03-1
Cyp2c23 protein, mouse EC 1.14.14.1
Cytochrome P450 Family 2 EC 1.14.14.1
8,11,14-Eicosatrienoic Acid FC398RK06S

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

F1369-F1376

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK054983
Pays : United States
Organisme : HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ID : DK54983
Pays : International

Références

J Gen Physiol. 2004 Dec;124(6):719-27
pubmed: 15545402
J Biol Chem. 2014 Feb 14;289(7):4377-86
pubmed: 24368771
N Engl J Med. 2009 May 7;360(19):1960-70
pubmed: 19420365
J Biol Chem. 2013 Feb 15;288(7):5223-31
pubmed: 23283969
Am J Physiol Renal Physiol. 2019 Mar 1;316(3):F582-F586
pubmed: 30623727
Hypertension. 2003 Oct;42(4):594-9
pubmed: 12939236
J Am Soc Nephrol. 2015 Nov;26(11):2678-90
pubmed: 25848073
Physiol Rev. 2002 Jan;82(1):131-85
pubmed: 11773611
J Biol Chem. 1999 Jun 4;274(23):16355-62
pubmed: 10347194
Kidney Int. 2018 Apr;93(4):893-902
pubmed: 29310825
Am J Physiol Renal Physiol. 2011 Jun;300(6):F1385-93
pubmed: 21454252
J Biol Chem. 2013 Sep 6;288(36):26135-46
pubmed: 23873931
Hypertension. 2019 Jan;73(1):112-120
pubmed: 30571558
JCI Insight. 2017 Sep 21;2(18):
pubmed: 28931751
J Clin Invest. 1994 Dec;94(6):2414-20
pubmed: 7989598
Hypertension. 2003 Mar;41(3 Pt 2):709-14
pubmed: 12623984
J Am Soc Nephrol. 2019 Feb;30(2):216-227
pubmed: 30559144
Am J Physiol. 1999 Mar;276(3):F367-81
pubmed: 10070160
Miner Electrolyte Metab. 1987;13(6):422-32
pubmed: 3320724
J Clin Invest. 2006 Jun;116(6):1696-702
pubmed: 16691295
J Gen Physiol. 2003 Apr;121(4):287-300
pubmed: 12668733
Sci Signal. 2014 May 06;7(324):ra41
pubmed: 24803536
J Clin Invest. 1999 Sep;104(6):751-60
pubmed: 10491410
Kidney Int. 2002 Feb;61(2):547-54
pubmed: 11849395
J Am Soc Nephrol. 2017 Jun;28(6):1814-1825
pubmed: 28052988
J Pharmacol Exp Ther. 1998 Mar;284(3):966-73
pubmed: 9495856
EMBO J. 1996 Jun 17;15(12):2980-7
pubmed: 8670799
Am J Physiol Renal Physiol. 2008 Jun;294(6):F1398-407
pubmed: 18367659
Am J Physiol Renal Physiol. 2014 Aug 15;307(4):F453-60
pubmed: 24966089
Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11864-9
pubmed: 25071208
Br J Pharmacol. 1999 Jul;127(6):1399-405
pubmed: 10455289
Hypertension. 2003 Oct;42(4):775-80
pubmed: 12900436
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10361-6
pubmed: 21633011
Am J Physiol. 1995 Dec;269(6 Pt 2):F900-10
pubmed: 8594886
J Pharmacol Exp Ther. 2004 Sep;310(3):845-54
pubmed: 15084647
J Pharmacol Exp Ther. 2001 Oct;299(1):39-47
pubmed: 11561061
J Am Soc Nephrol. 1996 Nov;7(11):2364-70
pubmed: 8959626
Clin Sci (Lond). 2006 Jul;111(1):21-34
pubmed: 16764555
Am J Physiol. 1987 Sep;253(3 Pt 2):F546-54
pubmed: 3631283
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14552-7
pubmed: 9826738
J Clin Invest. 1995 Nov;96(5):2510-4
pubmed: 7593642
J Am Soc Nephrol. 2015 Aug;26(8):1781-6
pubmed: 25542968
Kidney Int. 2007 Sep;72(6):683-9
pubmed: 17597703
Am J Physiol Renal Physiol. 2016 Jul 1;311(1):F12-5
pubmed: 27122539
J Biol Chem. 2001 Sep 28;276(39):36059-62
pubmed: 11451964
Am J Physiol Renal Physiol. 2011 Sep;301(3):F672-81
pubmed: 21697242
Am J Physiol Renal Physiol. 2000 Aug;279(2):F252-8
pubmed: 10919843

Auteurs

Ming-Xiao Wang (MX)

Department of Physiology, Zhuhai Campus of Zunyi Medical University, Zunyi, Guizhou, China.

Li-Jun Wang (LJ)

Department of Physiology, Harbin Medical University, Harbin, China.

Yu Xiao (Y)

Department of Physiology, Qiqihar Medical College, Heilongjiang, China.

Dan-Dan Zhang (DD)

Department of Pharmacology, New York Medical College, Valhalla, New York.

Xin-Peng Duan (XP)

Department of Pharmacology, New York Medical College, Valhalla, New York.

Wen-Hui Wang (WH)

Department of Pharmacology, New York Medical College, Valhalla, New York.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH